Dionigi E, Garcovich M, Borzio M, Leandro G, Majumdar A, Tsami A, et al. Bacterial infections change natural history of cirrhosis irrespective of liver disease severity. Am J Gastroenterol. 2017;112(4):588–96. https://doi.org/10.1038/ajg.2017.19.
Fernández J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67(10):1870–80. https://doi.org/10.1136/gutjnl-2017-314240.
Nahon P, Lescat M, Layese R, Bourcier V, Talmat N, Allam S, et al. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut. 2017;66(2):330–41. https://doi.org/10.1136/gutjnl-2015-310275.
Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019;156(5):1368-80.e10. https://doi.org/10.1053/j.gastro.2018.12.005.
Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–24. https://doi.org/10.1016/j.jhep.2014.01.024.
Magiorakos AP, Burns K, Rodríguez Baño J, Borg M, Daikos G, Dumpis U, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control. 2017;6:113. https://doi.org/10.1186/s13756-017-0259-z.
CHINET: https://www.chinets.com/Document/Index. Accessed 11 Febr 2022.
Gorrie CL, Mirceta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, et al. Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients. Clin Infect Dis. 2017;65(2):208–15. https://doi.org/10.1093/cid/cix270.
Dickstein Y, Edelman R, Dror T, Hussein K, Bar-Lavie Y, Paul M. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J Hosp Infect. 2016;94(1):54–9. https://doi.org/10.1016/j.jhin.2016.05.018.
Lin Q, Wang Y, Yu J, Li S, Zhang Y, Wang H, et al. Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection. BMC Infect Dis. 2021;21(1):638. https://doi.org/10.1186/s12879-021-06315-0.
Macesic N, Gomez-Simmonds A, Sullivan SB, Giddins MJ, Ferguson SA, Korakavi G, et al. Genomic surveillance reveals diversity of multidrug-resistant organism colonization and infection: a prospective cohort study in liver transplant recipients. Clin Infect Dis. 2018;67(6):905–12. https://doi.org/10.1093/cid/ciy199.
Geladari A, Karampatakis T, Antachopoulos C, Iosifidis E, Tsiatsiou O, Politi L, et al. Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department. Transpl Infect Dis. 2017;19:3. https://doi.org/10.1111/tid.12686.
Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing.CLSI M100 ED31:2021. Wayne: Clincal and Laboratory Standards Institute. 2021.
Testing TECoAS: http://www.eucast.org. Accessed 1 Jan 2021.
Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8(4):453–71. https://doi.org/10.1007/s12072-014-9580-2.
Chen HY, Jean SS, Lee YL, Lu MC, Ko WC, Liu PY, et al. Carbapenem-resistant Enterobacterales in long-term care facilities: a global and narrative review. Front Cell Infect Microbiol. 2021;11:601968. https://doi.org/10.3389/fcimb.2021.601968.
Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57(9):1246–52. https://doi.org/10.1093/cid/cit500.
Lee CM, Lai CC, Chiang HT, Lu MC, Wang LF, Tsai TL, et al. Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan. J Microbiol Immunol Infect. 2017;50(2):133–44. https://doi.org/10.1016/j.jmii.2016.12.001.
Chen H, Au KM, Hsu KE, Lai CK, Myint J, Mak YF, et al. Multidrug-resistant organism carriage among residents from residential care homes for the elderly in Hong Kong: a prevalence survey with stratified cluster sampling. Hong Kong Med J. 2018;24(4):350–60. https://doi.org/10.12809/hkmj176949.
Le MN, Kayama S, Yoshikawa M, Hara T, Kashiyama S, Hisatsune J, et al. Oral colonisation by antimicrobial-resistant Gram-negative bacteria among long-term care facility residents: prevalence, risk factors, and molecular epidemiology. Antimicrob Resist Infect Control. 2020;9(1):45. https://doi.org/10.1186/s13756-020-0705-1.
McKinnell JA, Singh RD, Miller LG, Kleinman K, Gussin G, He J, et al. The SHIELD orange county project: multidrug-resistant organism prevalence in 21 nursing homes and long-term acute care facilities in Southern California. Clin Infect Dis. 2019;69(9):1566–73. https://doi.org/10.1093/cid/ciz119.
Mao YC, Chang CL, Huang YC, Su LH, Lee CT. Laboratory investigation of a suspected outbreak caused by Providencia stuartii with intermediate resistance to imipenem at a long-term care facility. J Microbiol Immunol Infect. 2018;51(2):214–9. https://doi.org/10.1016/j.jmii.2016.07.004.
Yan L, Sun J, Xu X, Huang S. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital. Antimicrob Resist Infect Control. 2020;9(1):155. https://doi.org/10.1186/s13756-020-00816-4.
Rai S, Das D, Niranjan DK, Singh NP, Kaur IR. Carriage prevalence of carbapenem-resistant Enterobacteriaceae in stool samples: a surveillance study. Australas Med J. 2014;7(2):64–7. https://doi.org/10.4066/amj.2014.1926.
Pan F, Tian D, Wang B, Zhao W, Qin H, Zhang T, et al. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai. BMC Infect Dis. 2019;19(1):678. https://doi.org/10.1186/s12879-019-4298-3.
Tang HJ, Hsieh CF, Chang PC, Chen JJ, Lin YH, Lai CC, et al. Clinical significance of community- and healthcare-acquired carbapenem-resistant enterobacteriaceae isolates. PLoS One. 2016;11(3):e0151897. https://doi.org/10.1371/journal.pone.0151897.
Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar MV, Bilker WB, et al. Multicenter study of the risk factors for colonization or infection with carbapenem-resistant Enterobacteriaceae in children. Antimicrob Agents Chemother. 2017;61:12. https://doi.org/10.1128/aac.01440-17.
Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Rock C, et al. How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications? Infect Control Hosp Epidemiol. 2018;39(12):1491–3. https://doi.org/10.1017/ice.2018.236.
Prasad N, Labaze G, Kopacz J, Chwa S, Platis D, Pan CX, et al. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City. Am J Infect Control. 2016;44(5):525–32. https://doi.org/10.1016/j.ajic.2015.11.021.
Madueño A, González García J, Ramos MJ, Pedroso Y, Díaz Z, Oteo J, et al. Risk factors associated with carbapenemase-producing Klebsiella pneumoniae fecal carriage: a case-control study in a Spanish tertiary care hospital. Am J Infect Control. 2017;45(1):77–9. https://doi.org/10.1016/j.ajic.2016.06.024.
Freire MP, Oshiro IC, Pierrotti LC, Bonazzi PR, de Oliveira LM, Song AT, et al. Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes. Transplantation. 2017;101(4):811–20. https://doi.org/10.1097/tp.0000000000001620.
Pereira MR, Scully BF, Pouch SM, Uhlemann AC, Goudie S, Emond JE, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015;21(12):1511–9. https://doi.org/10.1002/lt.24207.
Phichaphop C, Apiwattanakul N, Techasaensiri C, Lertudomphonwanit C, Treepongkaruna S, Thirapattaraphan C, et al. High prevalence of multidrug-resistant gram-negative bacterial infection following pediatric liver transplantation. Medicine (Baltimore). 2020;99(45):e23169. https://doi.org/10.1097/md.0000000000023169.
Zhong L, Men T-Y, Li H, Peng Z-H, Gu Y, Ding X, et al. Multidrug-resistant gram-negative bacterial infections after liver transplantation–Spectrum and risk factors. J Infect. 2012;64(3):299–310. https://doi.org/10.1016/j.jinf.2011.12.005.
Zhang W, Wang W, Kang M, Wu S, Liu Y, Liao Q, et al. Bacterial and Fungal Infections After Liver Transplantation: Microbial Epidemiology, Risk Factors for Infection and Death with Infection. Ann Transpl. 2020;25:e921591. https://doi.org/10.12659/aot.921591.
Cheruvattath R, Balan V. Infections in Patients With End-stage Liver Disease. J Clin Gastroenterol. 2007;41(4):403–11. https://doi.org/10.1097/01.mcg.0000248018.08515.f9.
Iovleva A, Doi Y. Carbapenem-Resistant Enterobacteriaceae. Clin Lab Med. 2017;37(2):303–15. https://doi.org/10.1016/j.cll.2017.01.005.
Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: detection and antimicrobial therapy. Front Microbiol. 2019;10:1823. https://doi.org/10.3389/fmicb.2019.01823.
Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–72. https://doi.org/10.1016/j.molmed.2012.03.003.
Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, et al. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. 2020;10:314. https://doi.org/10.3389/fcimb.2020.00314.
Wang Q, Wang X, Wang J, Ouyang P, Jin C, Wang R, et al. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: data From a Longitudinal Large-scale CRE Study in China (2012–2016). Clin Infect Dis. 2018;67(supp_2):S196-s205. https://doi.org/10.1093/cid/ciy660.
Huang W, Zhang J, Zeng L, Yang C, Yin L, Wang J, et al. Carbapenemase Production and Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in Western Chongqing China. Front Cell Infect Microbiol. 2021;11:775740. https://doi.org/10.3389/fcimb.2021.775740.
Khan MA, Mohamed AM, Faiz A, Ahmad J. Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance. J Infect Dev Ctries. 2019;13(4):334–41. https://doi.org/10.3855/jidc.11056.
留言 (0)